Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

District Court finds that AKS Violations are Per Se Material

By Brett Barnett & Timothy Fry on March 31, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

Last month, the Central District of California granted the government’s affirmative motion for partial summary judgment in U.S. v. Reliance Medical Sys., 2022 WL 524062 (C.D. Cal. Feb. 2, 2022).  The Reliance Medical case involved an FCA action based on a theory that certain physician-owned distributorships (PODs) violated the Anti-Kickback Statute (AKS).  As detailed below, the Central District found – in accordance with the substantial majority of other courts – that violations of the AKS are material under the FCA.

The DOJ contended that several physician-investors in various spinal implant distribution companies (collectively, Reliance Medical Systems) recommended spinal fusion surgeries – even when not medically necessary – which compelled the need for Reliance Medical Systems’ spinal implant devices. Specifically, the government avers that between 2007 and 2013, four physician-investors in Reliance Medical Systems performed 268 surgeries resulting in 838 claims for payment to the United States, of which Medicare paid $9,250,611. The government sought partial summary judgment on the grounds that, as a matter of law, the physician-investors’ alleged AKS violations were material for purposes of the FCA.

It is well-established that compliance with the AKS is a precondition of Medicare payment, and the Affordable Care Act (ACA) explicitly provides that “a claim that includes items or services resulting from a violation of [the AKS] constitutes a false or fraudulent claim for the purposes of [the FCA].”

While the Reliance Medical court noted that the falsity and materiality elements are distinct, it also agreed with the majority of courts in holding that compliance with the AKS is per se material to the payment of Medicare claims. Citing various cases and quoting language articulated by the First Circuit, the court reasoned that the ACA “obviate[ed] the need for a plaintiff to plead materiality. . . . This construction inescapably follows from the statute’s plain language stating that a claim resulting from a violation of the AKS ‘constitutes a false or fraudulent claim.’” As such, the district court held that compliance with the AKS was per se material to the payment of Medicare claims following the enactment of the ACA. Nonetheless, the issue remained as to whether compliance with the AKS was per se material for claims predating the enactment of the ACA in 2010.

Again collecting cases and quoting the First Circuit, the district court held that “[t]he legislative history suggests that the 2010 amendment was intended to codify the link between AKS violations and false claims within the meaning of the FCA . . . .”  As such, the California court agreed with the majority of courts in holding that compliance with the AKS was per se material for claims predating the enactment of the ACA.

In sum, the court found that compliance with the AKS was per se material to the payment of Medicare claims as regards claims that pre and postdate the ACA’s 2010 enactment. Therefore, the court granted the government’s motion for partial summary judgment in substantial part. Of note, although the court found that the government was entitled to summary judgment on (1) the issue of materiality; and (2) the number of surgeries performed, number of Medicare claims made, and amount paid by Medicare from the resulting claims between 2007 and 2013, the court denied the government’s motion in part as it found a triable issue of fact as to the alleged status of the four physicians as physician-investors during that period.

Nonetheless, as it stands, courts are trending toward agreeing with the California district court and finding that compliance with the AKS is per se material for the payment of Medicare claims regardless of the date of the claim.

Photo of Brett Barnett Brett Barnett

Brett is the co-leader of McGuireWoods’ False Claims Act Investigations & Litigation Practice Group. He focuses his practice on representing clients in high-stakes False Claims Act matters, healthcare fraud and abuse investigations, and complex commercial litigation across the country. Brett routinely leads internal…

Brett is the co-leader of McGuireWoods’ False Claims Act Investigations & Litigation Practice Group. He focuses his practice on representing clients in high-stakes False Claims Act matters, healthcare fraud and abuse investigations, and complex commercial litigation across the country. Brett routinely leads internal and government-facing investigations involving the U.S. Department of Justice and other federal and state agencies, and defends clients in civil FCA litigation, often involving parallel proceedings and regulatory scrutiny.

Read more about Brett BarnettEmail
Show more Show less
Photo of Timothy Fry Timothy Fry

Tim resolves clients’ thorny compliance and regulatory issues that make or break healthcare transactions and operations. He delivers practical, business-oriented solutions that clear obstacles, close deals, and protect enterprise value.

Read more about Timothy FryEmail
  • Posted in:
    Banking, Finance and Securities, Health Care and Life Sciences
  • Blog:
    The FCA Insider
  • Organization:
    McGuireWoods LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo